SynthesisBMC pediatrics2022

Efficacy and safety of vedolizumab for pediatrics with inflammatory bowel disease: a systematic review.

Shengbo Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.